Aflibercept, bevacizumab, and ranibizumab all improve vision in eyes with center-involved diabetic macular edema, according to a randomized clinical trial. The relative effect of the three drugs ...
The Diabetic Retinopathy Clinical Research Network (DRCR.net) conducted a comparative effectiveness trial evaluating the prevalence of persistent diabetic macular edema (DME) and its effect on visual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback